• Regulatory Solutions
• Market Intelligence
• Supply Chain Management and Technical Services
• Orphan Drug Management

ORPHAN DRUG MANAGEMENT

Drugs that treat rare diseases with a prevalence of less than 5 per 10,000 people of the population are known as Orphan Drugs. High development costs, absence of a well-defined national health insurance scheme and the small scale of potential markets are the reasons research in rare diseases is seldom conducted. Hence such products face difficulties penetrating the Asia Pacific market.

At PharmaLink, making Orphan Drugs available for people suffering from rare diseases in Asia Pacific is one of our greatest priorities. We strive to bring Orphan Drugs to the market through utilising developed local networks of loyal prescribers and creating awareness for rare diseases.

To date, we have achieved improved outcomes for patients and our business partners by rigorous analytics and in-depth market knowledge.